Metzger Michael A insider trades
Metzger Michael A has filed 33 Form 4s with the SEC that we hold, for Syndax Pharmaceuticals Inc (SNDX) (Chief Executive Officer, Director), CTIC (Director) and Pyxis Oncology, Inc. (PYXS) (Director). Across all of them we count 0 purchases worth $0 and 44 sales worth $13.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($1.4M). The largest single trade was a sale of 157,307 shares of Syndax Pharmaceuticals Inc worth $2.6M, dated 2025-09-08. The first filing on our record is dated 2021-09-15 and the latest 2026-07-09.
Syndax Pharmaceuticals Inc (SNDX)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-09-13 | S, sale reported on Form 4 | 16,651 | $316.7K | 2021-09-15 | SEC |
| 2021-09-14 | S, sale reported on Form 4 | 44,349 | $849.3K | 2021-09-15 | SEC |
| 2021-09-20 | S, sale reported on Form 4 | 31,455 | $605.2K | 2021-09-22 | SEC |
| 2021-09-21 | S, sale reported on Form 4 | 4,808 | $92.1K | 2021-09-22 | SEC |
| 2021-09-22 | S, sale reported on Form 4 | 300 | $5.7K | 2021-09-22 | SEC |
| 2021-09-27 | S, sale reported on Form 4 | 24,437 | $476.8K | 2021-09-28 | SEC |
| 2021-10-25 | S, sale reported on Form 4 | 44,704 | $855.2K | 2021-10-27 | SEC |
| 2021-10-26 | S, sale reported on Form 4 | 16,296 | $312.9K | 2021-10-27 | SEC |
| 2021-12-13 | S, sale reported on Form 4 | 34,564 | $658.4K | 2021-12-15 | SEC |
| 2021-12-13 | S, sale reported on Form 4 | 2,045 | $39.0K | 2021-12-15 | SEC |
| 2021-12-16 | S, sale reported on Form 4 | 22,715 | $433.4K | 2021-12-20 | SEC |
| 2021-12-17 | S, sale reported on Form 4 | 1,676 | $31.9K | 2021-12-20 | SEC |
| 2021-12-20 | S, sale reported on Form 4 | 16,000 | $324.6K | 2021-12-20 | SEC |
| 2021-12-20 | S, sale reported on Form 4 | 45,000 | $913.0K | 2021-12-20 | SEC |
| 2022-07-06 | S, sale reported on Form 4 | 15,009 | $316.2K | 2022-07-08 | SEC |
| 2022-07-07 | S, sale reported on Form 4 | 100 | $2.1K | 2022-07-08 | SEC |
| 2022-07-25 | S, sale reported on Form 4 | 11,838 | $249.3K | 2022-07-27 | SEC |
| 2022-07-25 | S, sale reported on Form 4 | 19,764 | $416.2K | 2022-07-27 | SEC |
| 2022-09-30 | S, sale reported on Form 4 | 29,606 | $740.7K | 2022-10-04 | SEC |
| 2022-10-03 | S, sale reported on Form 4 | 2,883 | $72.1K | 2022-10-04 | SEC |
| 2022-10-04 | S, sale reported on Form 4 | 1,280 | $32.0K | 2022-10-04 | SEC |
| 2022-10-06 | S, sale reported on Form 4 | 16,231 | $410.5K | 2022-10-07 | SEC |
| 2023-02-06 | S, sale reported on Form 4 | 5,959 | $164.7K | 2023-02-08 | SEC |
| 2025-02-10 | S, sale reported on Form 4 | 13,288 | $206.0K | 2025-02-12 | SEC |
| 2025-03-04 | S, sale reported on Form 4 | 7,814 | $117.6K | 2025-03-06 | SEC |
| 2025-07-16 | S, sale reported on Form 4 | 7,534 | $70.0K | 2025-07-18 | SEC |
| 2025-09-08 | S, sale reported on Form 4 | 157,307 | $2.6M | 2025-09-08 | SEC |
| 2026-02-06 | S, sale reported on Form 4 | 7,412 | $152.8K | 2026-02-06 | SEC |
| 2026-02-09 | S, sale reported on Form 4 | 17,159 | $360.9K | 2026-02-10 | SEC |
| 2026-06-01 | S, sale reported on Form 4 | 6,847 | $130.0K | 2026-06-02 | SEC |
| 2026-07-08 | S, sale reported on Form 4 | 32,375 | $784.8K | 2026-07-09 | SEC |
CTIC
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-07-05 | S, sale reported on Form 4 | 27,506 | $168.9K | 2022-07-07 | SEC |
| 2022-07-05 | S, sale reported on Form 4 | 3,331 | $20.8K | 2022-07-07 | SEC |
| 2022-07-05 | S, sale reported on Form 4 | 51,963 | $314.4K | 2022-07-07 | SEC |
| 2022-07-05 | S, sale reported on Form 4 | 8,700 | $52.0K | 2022-07-07 | SEC |
| 2022-07-07 | S, sale reported on Form 4 | 5,900 | $38.4K | 2022-07-11 | SEC |
| 2022-07-07 | S, sale reported on Form 4 | 3,321 | $21.7K | 2022-07-11 | SEC |
| 2022-07-07 | S, sale reported on Form 4 | 400 | $2.6K | 2022-07-11 | SEC |
| 2022-07-07 | S, sale reported on Form 4 | 400 | $2.6K | 2022-07-11 | SEC |
| 2022-07-07 | S, sale reported on Form 4 | 1,100 | $7.2K | 2022-07-11 | SEC |
| 2022-07-07 | S, sale reported on Form 4 | 9,000 | $58.5K | 2022-07-11 | SEC |
| 2022-11-08 | S, sale reported on Form 4 | 50,058 | $276.8K | 2022-11-10 | SEC |
| 2022-11-08 | S, sale reported on Form 4 | 36,942 | $208.7K | 2022-11-10 | SEC |
| 2022-11-08 | S, sale reported on Form 4 | 4,500 | $25.6K | 2022-11-10 | SEC |
Pyxis Oncology, Inc. (PYXS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1507220) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
